The Explainer Is the EU-US tariff deal the best we could do?
Jul 30, 2025
Dr. Emma Howard, an economist and lecturer at TU Dublin, dissects the recent EU-US tariff deal, revealing its complex implications for international trade. She discusses the significant tariffs impacting vital sectors like pharmaceuticals and whiskey, highlighting the asymmetrical benefits favoring the US. Emma also examines the reliability of trade partnerships and internal EU conflicts affecting negotiations, while assessing the broader impact on consumer prices and economies on both sides of the Atlantic.
AI Snips
Chapters
Transcript
Episode notes
Major Tariff Increase For EU Goods
- Most EU goods will face a 15% tariff entering the US, a big increase from the previous 1.4% average tariff.
- Conflicting reports exist about tariff exemptions on pharma and aviation, adding to uncertainty for exporters.
Asymmetric Deal and Unrealistic Energy Goals
- The deal is asymmetric: the EU faces tariffs on its exports while the US largely avoids tariffs on theirs.
- EU commitment to massive US energy imports is unrealistic and conflicts with EU green goals.
Investment Pledges and Military Buying Confusion
- The EU pledged $600 billion investment in the US economy, mostly continuing existing trends rather than new commitments.
- Confusion over alleged EU weapons purchase commitments added tension to negotiations post-agreement.